Substituted pyrazoles as type II IRAK inhibitors
US11873303B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2019 |
| Grant date | Jan 16, 2024 |
| Priority date | — |
| Expiry date | Jan 20, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.